Medicine and Dentistry
Multiple Endocrine Neoplasia Type I
100%
Differentiated Thyroid Cancer
79%
Pheochromocytoma
59%
Paraganglioma
59%
Neuroendocrine Tumor
45%
Pancreas Islet Cell Tumor
36%
Neck
32%
Neoplasm
32%
Radioactive Iodine
30%
Thyroid Cancer
29%
Carcinoid
28%
Positron Emission Tomography
28%
Disease
28%
Metastatic Carcinoma
27%
Metanephrine
25%
Succinate Dehydrogenase
22%
Von Hippel-Lindau Disease
22%
Scintigraphy
21%
Catecholamine
20%
Quality of Life
18%
Liver Metastasis
18%
DOPA
18%
Urinary System
17%
Iodine 131
17%
Midgut
17%
Glycon
17%
Diagnosis
17%
Positron Emission Tomography-Computed Tomography
16%
Germline Mutation
14%
Cross Sectional Study
13%
Diagnostic Accuracy
13%
Observational Study
13%
Catheter Ablation
13%
ST Segment Elevation Myocardial Infarction
13%
Fluorine-18
13%
Prognostic Factor
12%
Iodine 123
11%
Salivary Gland Function
11%
Thyroglobulin
11%
Pediatrics
11%
Diabetes
10%
Placebo
10%
Prevalence
10%
Normetanephrine
10%
Ablation Therapy
10%
Primary Hyperparathyroidism
10%
Pituitary Tumour
9%
Hazard Ratio
9%
Positron Emission Tomography
9%
Surgery
8%
Pharmacology, Toxicology and Pharmaceutical Science
Differentiated Thyroid Cancer
69%
Multiple Endocrine Neoplasia Type 1
40%
Pheochromocytoma
39%
Paraganglioma
36%
Thyroid Cancer
29%
Carcinoid
28%
Iodine-131
27%
Neuroendocrine Tumor
27%
Disease
25%
Metformin
22%
ST Segment Elevation Myocardial Infarction
18%
Metadrenalin
17%
Metastasis
15%
Cardiovascular Risk
14%
Placebo
13%
Succinate Dehydrogenase
13%
Radioactive Iodine
13%
Neoplasm
12%
Brain Natriuretic Peptide
12%
Catecholamine
12%
Observational Study
12%
Thyroglobulin
11%
DOPA
11%
Liver Metastasis
11%
Acute Heart Infarction
11%
Prevalence
10%
Normetadrenalin
10%
Carcinoid Syndrome
10%
Serotonin
10%
Antihypertensive Agent
8%
Cross-Sectional Study
7%
Primary Hyperparathyroidism
7%
Normal Human
7%
5 Hydroxyindoleacetic Acid
6%
Thyrotropin
6%
Receptor
6%
Tumor Syndrome
6%
Randomized Controlled Trial
6%
Thyroid Medullary Carcinoma
6%
Creatinine
6%
Fluorine 18
6%
Progression Free Survival
5%
Succinic Acid
5%
Thyroid Carcinoma
5%
Protein Tyrosine Kinase Inhibitor
5%
Heart Metastasis
5%
Venous Thromboembolism
5%
Non Insulin Dependent Diabetes Mellitus
5%
Somatostatin Receptor
5%
Von Hippel Lindau Disease
5%
Keyphrases
Pheochromocytoma
41%
Differentiated Thyroid Carcinoma
35%
Multiple Endocrine Neoplasia Type 1 (MEN1)
34%
Paraganglioma
23%
Neck Paragangliomas
19%
Head-and-neck
19%
Dopamine
17%
Dutch
16%
Tumor
15%
Pancreatic Neuroendocrine Tumors (pNETs)
15%
Mutation Carriers
14%
Sympathetic Paraganglioma
13%
Survivors
13%
Von Hippel-Lindau Disease
11%
Succinate Dehydrogenase B
11%
Carcinoid Tumor
11%
Midgut Carcinoid
11%
F-18
11%
Radioiodine Treatment
11%
ST-elevation Myocardial Infarction (STEMI)
11%
Von Hippel-Lindau
11%
Metformin
10%
131I Therapy
10%
Catecholamines
10%
Metformin Treatment
9%
Metanephrines
9%
Differentiated Thyroid Cancer
9%
Placebo
9%
Risk Factors
9%
Thyroglobulin
8%
Netherlands
8%
Nonfunctional Pancreatic Neuroendocrine Tumor
8%
Without Diabetes
8%
Tumor Syndrome
7%
Carcinoid Syndrome
7%
Neuroendocrine Tumor
6%
Cardiovascular Risk
6%
Normetanephrine
6%
Confidence Interval
6%
Primary Hyperparathyroidism (pHPT)
6%
Plasma Metanephrines
6%
Additional Value
6%
Metastatic Disease
6%
Natural Course
6%
Blood Platelets
6%
Germline mutation
6%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
5%
Primary Care Setting
5%
Neovascularization
5%
HNPGL
5%
